Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironment

9 Aug 2025

Abstract excerpt

OBJECTIVE: Lipid metabolic reprogramming enables tumor cells to acquire malignant phenotypes, including enhanced proliferative capacity, migratory potential, and invasive properties. In cervical cancer, the precise pathobiological roles and molecular mechanisms of DHCR24 remain unclear. METHODS: We performed comprehensive bioinformatics analyses to investigate the expression patterns, clinical relevance, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer, Lipids, and Metabolism
Share to Cancer, Stress, Anesthesia, and Immune Response
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40783686
DOI: 10.1186/s12885-025-14663-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DHCR24 overexpression is involved in lipid metabolic reprogramming to drive cervical cancer malignant progression and is associated with immune microenvironmentPMID 40783686Read ↗

Cervical cancer subtype identification and model building based on lipid metabolism and post-infection microenvironment immune landscapeSemantic proximity Read ↗

DHCR24 in Tumor Diagnosis and Treatment: A Comprehensive ReviewSemantic proximity Read ↗

A pan-cancer analysis of the oncogenic role of 7-dehydrocholesterol reductase (DHCR7) in human tumorsSemantic proximity Read ↗

DHCR7 as a Prognostic and Immunological Biomarker in Human Pan-Cancer: A Comprehensive Evaluation.Semantic proximity Read ↗

Novel fatty acid metabolism biomarkers reveal prognosis and immune microenvironment in cervical cancerSemantic proximity Read ↗

Expression profiling of cervical cancers in <scp>I</scp>ndian women at different stages to identify gene signatures during progression of the diseaseSemantic proximity Read ↗

hIL-24: A Promising Therapeutic Target for Cervical Cancer Running Title: Targeting hIL-24 in Cervical CancerSemantic proximity Read ↗

DHCR7 is a potential pan cancer biomarker for prognosis and immunotherapySemantic proximity Read ↗

Lipid-Metabolism-Related Gene Signature Predicts Prognosis and Immune Microenvironment Alterations in Endometrial CancerSemantic proximity Read ↗

Lactylation prognostic signature identifies DHCR7 as a modulator of chemoresistance and immunotherapy efficacy in bladder cancerSemantic proximity Read ↗

Novel fatty acid metabolism biomarkers of immunotherapy response in cervical cancerSemantic proximity Read ↗

Metabolic Molecule PLA2G2D Is a Potential Prognostic Biomarker Correlating With Immune Cell Infiltration and the Expression of Immune Checkpoint Genes in Cervical Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.